A Preliminary Integrated Metabolomics Analysis Identifies Retrograde Endocannabinoid Signaling Shift in Severe OSA Patients. Han L, Liu J, Xu J, Li X, et al. Sleep Breath 2025;29:259.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Han L, Liu J, Xu J, Li X, et al. A Preliminary Integrated Metabolomics Analysis Identifies Retrograde Endocannabinoid Signaling Shift in Severe OSA Patients. Sleep Breath 2025;29:259.
PMID: 40742621